Security key
81619Q105
SELECT MEDICAL HOLDINGS CORP - Common Stock, par value $0.001 per share (SEM)
CUSIP: 81619Q105
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 124,104,146
- Total 13F shares
- 97,741,383
- Share change
- -2,499,906
- Total reported value
- $1,592,006,729
- Price per share
- $16.29
- Number of holders
- 273
- Value change
- -$28,089,052
- Number of buys
- 138
- Number of sells
- 132
Report period
Q1 2026
Institutions
273
Top holders
10
SEM full security history
Previous quarter: Q4 2025
SELECT MEDICAL HOLDINGS CORP SEC filings
SELECT MEDICAL HOLDINGS CORP company facts
Broader feeds
Reporting periods
Holder history for CUSIP 81619Q105
Recent filing periods:
Top shareholders of SEM - SELECT MEDICAL HOLDINGS CORP - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
|
Company |
12%
|
16,015,179
|
$294,839,445 | -$72,613,311 | 31 Mar 2025 | |
| Robert A. Ortenzio |
13D/G
3/4/5
|
ORTENZIO ROBERT A · EXECUTIVE CHAIRMAN, Director |
11%
|
14,019,735
|
$209,595,038 | $0 | 02 Mar 2026 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13D/G
|
Vanguard Portfolio Management |
5.4%
|
6,764,889
|
$110,200,042 | $0 | 31 Mar 2026 | |
| Rocco A. Ortenzio |
3/4/5
13D/G
|
CHAIRMAN EMERITUS & CO-FOUNDER · Estate of Rocco A. Ortenzio |
3.2%
from 13D/G
|
7,890,355
|
$269,692,334 | — | 30 Sep 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
13D/G
|
Company · T. Rowe Price Associates, Inc. |
0.1%
from 13D/G
|
16,606,269
|
$246,604,000 | — | 31 Dec 2025 | |
| Martin F. Jackson |
3/4/5
|
EXECUTIVE VICE PRESIDENT |
1.1%
|
1,388,689
|
$17,467,671 | — | 01 Aug 2025 | |
| John A. Saich |
3/4/5
|
EXECUTIVE VICE PRESIDENT |
0.59%
|
736,412
|
$9,256,698 | — | 01 Aug 2025 | |
| Russell L. Carson |
3/4/5
|
Director |
0.49%
|
610,035
|
$9,040,718 | — | 29 Apr 2025 | |
| Michael E. Tarvin |
3/4/5
|
EXECUTIVE VICE PRESIDENT |
0.41%
|
508,120
|
$6,387,068 | — | 01 Aug 2025 | |
| Thomas P. Mullin |
3/4/5
|
CO-PRESIDENT |
0.32%
|
391,709
|
$4,923,782 | — | 01 Aug 2025 | |
| Brian R. Rusignuolo |
3/4/5
|
Chief Information Officer |
0.29%
|
361,370
|
$4,542,420 | — | 01 Aug 2025 | |
| Michael F. Malatesta |
3/4/5
|
CHIEF FINANCIAL OFFICER |
0.19%
|
238,057
|
$3,292,328 | — | 01 Nov 2025 | |
| John F. Duggan |
3/4/5
|
Executive Vice President |
0.16%
|
194,710
|
$2,692,839 | — | 01 Nov 2025 | |
| James S. Ely III |
3/4/5
|
Director |
0.13%
|
161,674
|
$2,396,008 | — | 29 Jul 2025 | |
| John Tyler Hollenbach |
3/4/5
|
Executive Vice President |
0.11%
|
135,084
|
$2,005,997 | — | 01 Jan 2026 | |
| Thomas Scully |
3/4/5
|
Director, 10%+ Owner |
0.08%
|
103,424
|
$1,532,743 | — | 29 Jul 2025 | |
| Daniel Thomas |
3/4/5
|
Director |
0.06%
|
80,035
|
$1,186,118 | — | 29 Jul 2025 | |
| Parvinderjit S. Khanuja |
3/4/5
|
Director |
0.06%
|
79,124
|
$1,172,617 | — | 29 Jul 2025 | |
| Katherine R. Davisson |
3/4/5
|
Director |
0.05%
|
60,035
|
$889,718 | — | 29 Jul 2025 | |
| Christopher Weigl |
3/4/5
|
CHIEF ACCOUNTING OFFICER |
0.04%
|
54,254
|
$696,621 | — | 28 Oct 2025 | |
| Marilyn B. Tavenner |
3/4/5
|
Director |
0.03%
|
36,035
|
$534,038 | — | 29 Jul 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
10%
|
12,477,780
|
$185,295,034 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
4.3%
|
5,333,595
|
$79,204,582 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.5%
|
4,397,112
|
$65,297,113 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.5%
|
3,117,638
|
$46,303,912 | — | 31 Dec 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2.3%
|
2,826,987
|
$41,981,000 | — | 31 Dec 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.8%
|
2,211,898
|
$32,846,685 | — | 31 Dec 2025 | |
| Western Standard LLC |
13F
|
Company |
1.7%
|
2,064,021
|
$30,650,712 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.4%
|
1,686,737
|
$25,048,044 | — | 31 Dec 2025 | |
| Woodline Partners LP |
13F
|
Company |
1.1%
|
1,340,197
|
$19,901,925 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1%
|
1,298,453
|
$19,282,026 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1%
|
1,293,749
|
$19,212,173 | — | 31 Dec 2025 | |
| Hood River Capital Management LLC |
13F
|
Company |
1%
|
1,266,887
|
$18,813,272 | — | 31 Dec 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.96%
|
1,185,399
|
$17,603,175 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.86%
|
1,062,284
|
$15,774,914 | — | 31 Dec 2025 | |
| Prosight Management, LP |
13F
|
Company |
0.83%
|
1,035,086
|
$15,371,027 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.82%
|
1,022,061
|
$15,177,606 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.78%
|
966,710
|
$14,355,665 | — | 31 Dec 2025 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.75%
|
927,397
|
$13,772,000 | — | 31 Dec 2025 | |
| Eversept Partners, LP |
13F
|
Company |
0.73%
|
906,100
|
$13,455,585 | — | 31 Dec 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.64%
|
788,380
|
$11,707,443 | — | 31 Dec 2025 | |
| Dana Investment Advisors, Inc. |
13F
|
Company |
0.55%
|
678,545
|
$10,076,393 | — | 31 Dec 2025 | |
| Cambria Investment Management, L.P. |
13F
|
Company |
0.45%
|
557,494
|
$8,278,786 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.44%
|
548,153
|
$8,140,072 | — | 31 Dec 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.42%
|
527,171
|
$7,828,493 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.4%
|
496,646
|
$7,375,199 | — | 31 Dec 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.4%
|
492,505
|
$7,313,699 | — | 31 Dec 2025 | |
| Empowered Funds, LLC |
13F
|
Company |
0.38%
|
471,875
|
$7,007,344 | — | 31 Dec 2025 | |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.37%
|
464,559
|
$6,898,701 | — | 31 Dec 2025 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.31%
|
381,416
|
$5,664,028 | — | 31 Dec 2025 |
Institutional Holders of SELECT MEDICAL HOLDINGS CORP - Common Stock, par value $0.001 per share (SEM) as of Q1 2026
As of 31 Mar 2026,
SELECT MEDICAL HOLDINGS CORP - Common Stock, par value $0.001 per share (SEM) was held by
273 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
97,741,383 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD PORTFOLIO MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, FIL Ltd, VANGUARD CAPITAL MANAGEMENT LLC, STATE STREET CORP, GLAZER CAPITAL, LLC, GEODE CAPITAL MANAGEMENT, LLC, HSBC HOLDINGS PLC, and GOLDMAN SACHS GROUP INC.
This page lists
273
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
267
Q1 2026 holders
273
Holder diff
6
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.